It needs to be emphasized that, although HLA-B*39 was found to be significantly lower in patients with DLBCL compared with controls, this polymorphism is very rare among Greek individuals (Arnaiz-Villena et al., 2001), and, given the small sample size of our study, conclusions regarding its significance are limited. Here, HLA-B is linked to diffuse large B-cell lymphoma.